IFNG and hematologic disorder: Interferon gamma release assay (IGRA) testing has better sensitivity in detecting previous tuberculosis exposure in patients with hematological malignancies as reported by Richeldi and colleagues (17.9% to 26.3% vs. 10.5% for TST) but may also be hampered by the pancytopenia present in acute leukemia [10].